Mississauga, ON -- (SBWire) -- 11/19/2014 --AllPennyStocks.com Media, Inc. (http://www.AllPennyStocks.com/) announces its latest article titled “Event Cardio Group Acquires Global Rights to Cardiac Monitoring Device.”

Companies mentioned in this article include Event Cardio Group Inc. (OTCQB:ECGI).

Article Excerpt:

Ever had a funky heartbeat? You’re not alone as about half of the world’s population has cardiac arrhythmias, simply meaning that the heart doesn’t beat as it typically should. Many arrhythmias are harmless, but there are others that are cause for concern, such as ventricular fibrillation, a condition where chaotic electric signals are sent throughout the lower chamber of the heart, causing it to quiver and eventually stop beating. Atrial fibrillation is in the upper chambers and while not life-threatening, increases the likelihood of a stroke. Because of the often erratic nature of arrhythmias, they can often be difficult to diagnose. The most common choice of physicians is a Holter monitor, a sort of portable electrocardiography, or ECG, device the uses leads and a central processing unit to continuously record cardiac activity. The data collected on the CPU is sent to a cardiologist for analysis. Historically, the diagnostic yield hasn’t been that great from event recorders, ranging around 65% at best. Anyone who has ever had to wear a Holter monitor for a couple weeks as a means to try and pinpoint an arrhythmia knows that they can be a nuisance with patches stuck to the skin, wires dangling, and the central unit hooked to a belt or on a lanyard around the neck.

The landscape for Holter monitors is getting better anyway with companies developing new technologies to better capture arrhythmia events while making the system more comfortable. San Francisco’s iRhythm Technologies markets the ZIO XT Patch, a one-lead ECG sensor (no bulky CPU or wires) that is stuck to the patient’s chest for 7-14 days of continuous monitoring. Once the prescribed time is over, the patient peels off the ZIO patch and sends it to iRhythm for analysis via proprietary algorithms with a final report sent on to the physician. Researchers at the Scripps Translational Science Institute reported that clinical studies showed the ZIO patch leads to definitive diagnosis 90 percent of the time.

New York’s Event Cardio Group Inc. (OTCQB:ECGI) is making a bid to step up the technology too. The company, which had no operations since December 2008, went through a name and ticker change from Sunrise Holdings Limited and “SUIP” to its current state as the result of a recently completed reverse merger. Event Cardio trumpets its in-development Now Cardio as the world’s first non-invasive continuous heart monitor device that is both leadless and wireless, conducting both a loop recorder and Holter testing simultaneously. The company says that Now Cardio is being designed to be able to transfer data for intervals lasting up to 60 days and expects that the device will be able to receive both atrial and ventricular data from as far away as 1,000 feet away from the home-based receiver. Using any number of data transmission vehicles (landline, cellular, satellite, etc.) the data will be sent to a control center for continuous monitoring all day, every day. Event Cardio believes it can achieve definitive diagnostic yields in excess of 90 percent.

The full version of this article can be found at:
http://www.allpennystocks.com/aps_us/special-reports/488/event-cardio-group-acquires-global-rights-to-cardiac-monitoring-device.htm

About AllPennyStocks.com
AllPennyStocks.com is focused on the small-cap / penny stock market and has become a reputable name in the investment community. AllPennyStocks.com runs a Canadian and US site to provide investors in Canada as well as the United States with informative and unique content and information. AllPennyStocks.com runs daily technical penny stocks to watch, has a daily market write-up, provides company spotlights, runs unique most active pages strictly for penny stocks trading on the TSX, TSX Venture, NASDAQ and OTC BB, and much more information for the average investor.

AllPennyStocks.com also runs an email newsletter that aims to uncover stocks that are still under the radar of most investors. Criteria AllPennyStocks.com looks for includes strong revenues, a seasoned management, innovative business plans, among many others. AllPennyStocks.com also looks for companies that announce breaking news, recent 52-week highs/lows, technical breakouts, and other favorable corporate information.

Investors are encouraged to subscribe to the AllPennyStocks.com FREE e-mail newsletter and see what tens of thousands of other investors have already been receiving since 1999. Investors can receive their free newsletter subscription by clicking here: http://www.allpennystocks.com/aps_common/newsletter_free.asp.

Contact:

AllPennyStocks.com Media, Inc.
Peter Szafranski -- President
Phone: (905) 361-5680
E-Mail: peter@allpennystocks.com
Websites: http://www.allpennystocks.com / http://www.bullishinvestor.com

Note: AllPennyStocks.com has not received compensation for carrying the above-mentioned company; a full disclaimer can be viewed here: http://www.allpennystocks.com/aps_common/disclaimer.asp.